High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease.
H Bryan
HB
Brewer
D000818:Animals; D001161:Arteriosclerosis / Q000097:blood / Q000517:prevention & control; D001692:Biological Transport; D002318:Cardiovascular Diseases / Q000097:blood / Q000517:prevention & control*; D002352:Carrier Proteins / Q000037:antagonists & inhibitors / Q000502:physiology; D002784:Cholesterol / Q000378:metabolism; D053480:Cholesterol Ester Transfer Proteins; D008076:Cholesterol, HDL / Q000097:blood; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006023:Glycoproteins / Q000037:antagonists & inhibitors / Q000502:physiology; D006801:Humans; D008075:Lipoproteins, HDL / Q000502:physiology*; D008099:Liver / Q000378:metabolism; D008264:Macrophages / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D010084:Oxidation-Reduction; D011804:Quinolines / Q000494:pharmacology / Q000627:therapeutic use; D011817:Rabbits; D012307:Risk Factors
C506642:CETP protein, human; D002352:Carrier Proteins; D053480:Cholesterol Ester Transfer Proteins; D008076:Cholesterol, HDL; D004791:Enzyme Inhibitors; D006023:Glycoproteins; D008075:Lipoproteins, HDL; D011804:Quinolines; C483909:torcetrapib; D002784:Cholesterol